Low positivity rate after systematic screening forTrichomonas vaginalisin three patient cohorts from general practitioners, STI clinic and a national population-based chlamydia screening study: Table 1

Screening of Male Patients for Trichomonas vaginalis with Transcription-Mediated Amplification in a Community with a High Prevalence of Sexually Transmitted Infection

(2012) Kimber L. Munson et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Female Epidemiology of Transcription-Mediated Amplification-Based Trichomonas vaginalis Detection in a Metropolitan Setting with a High Prevalence of Sexually Transmitted Infection

(2012) E. Munson et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Prevalence of Trichomonas vaginalis and Coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as Determined by the Aptima Trichomonas vaginalis Nucleic Acid Amplification Assay

(2012) C. C. Ginocchio et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Re-screeningChlamydia trachomatispositive subjects: a comparison of practices between an STI clinic, general practitioners and gynaecologists: Table 1

(2012) Nicole H T M Dukers-Muijrers et al.   SEXUALLY TRANSMITTED INFECTIONS

Comparison of self-obtained penile-meatal swabs to urine for the detection ofC. trachomatis,N. gonorrhoeaeandT. vaginalis: Table 1

(2012) Laura Dize et al.   SEXUALLY TRANSMITTED INFECTIONS

Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation

(2012) I. V. F. van den Broek et al.   BMJ-British Medical Journal